BeOne Medicines Ltd.
Close on Nov 2, 2026Market cap $41.08BP/E 64.6Yield –
BeOne Medicines Payments & Credits Applied Against Sales Rebates by Year
Payments & Credits Applied Against Sales Rebates & Returns Reserve ($M) ($M)
BeOne Medicines Payments & Credits Applied Against Sales Rebates: $1,258M in FY2025, up 41.1% from a year earlier. That is the highest of the 9 years on record here.
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-26) ↗
Reported in Form 10-Q / 10-K Accrued Sales Rebates Rollforward Note (XBRL).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Payments & Credits Applied Against Sales Rebates & Returns Reserve ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1,258 | +41.1% | Form 10-K (filed 2026-02-26) ↗ |
| FY2024 | Dec 31, 2024 | 891 | +117.9% | Form 10-K (filed 2026-02-26) ↗ |
| FY2023 | Dec 31, 2023 | 409 | +102.8% | Form 10-K (filed 2025-02-27) ↗ |
| FY2022 | Dec 31, 2022 | 202 | +200.6% | Form 10-K (filed 2024-02-26) ↗ |
| FY2021 | Dec 31, 2021 | 67.1 | +845.1% | Form 10-K (filed 2023-02-27) ↗ |
| FY2020 | Dec 31, 2020 | 7.10 | -7.8% | Form 10-K (filed 2022-02-28) ↗ |
| FY2019 | Dec 31, 2019 | 7.70 | +20.3% | Form 10-K (filed 2021-02-25) ↗ |
| FY2018 | Dec 31, 2018 | 6.40 | – | Form 10-K (filed 2020-03-02) ↗ |
| FY2017 | Dec 31, 2017 | 0 | – | Form 10-K (filed 2019-02-28) ↗ |
Cite this data
StockData. (2026). BeOne Medicines Payments & Credits Applied Against Sales Rebates ($M), annual FY2017–FY2025 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/gtn-payments
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.